Thumbnail - Request a copy

Design and rationale of the Edoxaban Treatment in routiNe clinical prActice for patients with Atrial Fibrillation in Europe (ETNA-AF-Europe) study

De Caterina, Raffaele; Kelly, Peter; Monteiro, Pedro; Deharo, Jean Claude; de Asmundis, Carlo; López-de-Sá, Esteban; Weiss, Thomas W.; Waltenberger, Johannes; Steffel, Jan; de Groot, Joris R.; Lévy, Pierre; Bakhai, Ameet; Zierhut, Wolfgang; Laeis, Petra; Reimitz, Paul-Egbert; Kirchhof, Paulus (2019), Design and rationale of the Edoxaban Treatment in routiNe clinical prActice for patients with Atrial Fibrillation in Europe (ETNA-AF-Europe) study, Journal of Cardiovascular Medicine, 20, 2, p. 97-104. 10.2459/JCM.0000000000000737

Type
Article accepté pour publication ou publié
Date
2019
Journal name
Journal of Cardiovascular Medicine
Volume
20
Number
2
Publisher
Wolters Kluwer
Pages
97-104
Publication identifier
Metadata
Show full item record
Author(s)
De Caterina, Raffaele
Institute of Clinical Physiology
Kelly, Peter
NS Research
Division of Medicine
Neurovascular Clinical Science Unit, Catherine McAuley Centre
Monteiro, Pedro

Deharo, Jean Claude
Département de Cardiologie [Hôpital de la Timone - APHM]
de Asmundis, Carlo

López-de-Sá, Esteban

Weiss, Thomas W.

Waltenberger, Johannes

Steffel, Jan

de Groot, Joris R.

Lévy, Pierre
Laboratoire d'Economie de Dauphine [LEDa]
Laboratoire d'Economie et de Gestion des Organisations de Santé [Legos]
Bakhai, Ameet

Zierhut, Wolfgang
Department of Medicine, Royal Free [DEPARTMENT OF MEDICINE, ROYAL FREE]
Laeis, Petra
Daiichi Sankyo Inc.
Reimitz, Paul-Egbert

Kirchhof, Paulus
Subjects / Keywords
Prospective Studies; Europe; epidemiology; Treatment Outcome; ETNA-AF-Europe study; PREFER in AF
JEL
I12 - Health Behavior
I11 - Analysis of Health Care Markets